全部| 求助中| 待确认 按时间排序|按积分排序

Trastuzumab deruxtecan in HER2 overexpressing non-small cell lung cancer (NSCLC)

用户EO9nReo4Hj6s 7分钟前 10 已关闭

Rhabdomyosarcoma spheroids with central proliferation and differentiation

用户vP8pXEQ9CLS0 18分钟前 10 求助中

Trastuzumab Deruxtecan in Patients With HER2-Overexpressing NSCLC: Results From Part 1 of the Open-Label, Multicenter, Phase 1b DESTINY-Lung03 Trial

用户EO9nReo4Hj6s 21分钟前 10 已关闭

Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort

用户EO9nReo4Hj6s 31分钟前 10 求助中

Loss of Payload Sensitivity and Other Mechanisms of Resistance to T-DXd in HER2-Mutant NSCLC: Implications for Subsequent Responsiveness to HER2 TKIs

用户EO9nReo4Hj6s 32分钟前 10 求助中

BPI26-027: Multidisciplinary Practice Patterns in HER2-Mutant NSCLC: Insights to Inform Precision Oncology Education

用户EO9nReo4Hj6s 32分钟前 10 求助中

ERBB2 activating mutations and co-occurring genomic alterations contribute to disease heterogeneity in patients with ERBB2-mutant lung cancer

用户EO9nReo4Hj6s 40分钟前 10 求助中

Decreased rat rhabdomyosarcoma pulmonary metastases in response to a low methionine diet

用户vP8pXEQ9CLS0 46分钟前 10 求助中

A comparison of five transition programmes for youth with chronic illness in Canada

用户RgtDBKswacIA 57分钟前 10 求助中

Transition care for young people with chronic illness

用户RgtDBKswacIA 1小时前 10 待确认
首页 1 2 3 4 下页

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com